Figure 1From: Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data The base case strategies with ‘days until the first event’ (myocardial infarction, stroke or death) as the health outcome and cost until death in the cost-effectiveness plane with the expansion path. Costs were inflated to the year 2010. Both costs and effects were discounted at 5%. All: KardioPro for all risk groups. CHD: KardioPro for coronary heart disease patients group. High: KardioPro for high-risk group. Medium: KardioPro for medium-risk group. Low: KardioPro for low-risk group. High and CHD: KardioPro for high-risk and coronary heart disease patients groups. Middle, high and CHD: KardioPro for middle-risk, high-risk and coronary heart disease patients groups. Middle and high: KardioPro for middle-risk and high-risk groups. None: KardioPro for none.Back to article page